Monsanto's misery

The GM giant scales down its plans for growth in Europe in the face of public opposition to its products.

Written byPat Hagan
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The full scale of public opposition in Europe to genetically-modified crops has been highlighted by US corporation Monsanto's announcement that it's likely to be at least another three years before if can win approval there for its GM products.

Hendrik Verfaillie, the company's chief executive, said in an interview with the Financial Times that such is the resistance to GM crops that it is now assuming there will be no progress in Europe until 2005 at the earliest.

"We are trying to be conservative," he was reported as saying. "It is better to under-promise than under-deliver."

The company has already conceded that profits this year will be a third lower than it originally hoped for. The more bearish outlook follows hard on the heels of the latest GM crop debacle in the UK. The Department for the Environment, Food and Rural Affairs has ordered an investigation after it emerged that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
December digest cover image of a wooden sculpture comprised of multiple wooden neurons that form a seahorse.
December 2025, Issue 1

Wooden Neurons: An Artistic Vision of the Brain

A neurobiologist, who loves the morphology of cells, turns these shapes into works of art made from wood.

View this Issue
Stacks of cell culture dishes, plates, and flasks with pink cell culture medium on a white background.

Driving Innovation with Cell Culture Essentials

Merck
Stacks of cell culture dishes, plates, and flasks with pink cell culture medium on a white background.

Driving Innovation with Cell Culture Essentials

MilliporeSigma purple logo
Abstract wireframe sphere with colorful dots and connecting lines representing the complex cellular and molecular interactions within the tumor microenvironment.

Exploring the Inflammatory Tumor Microenvironment 

Cellecta logo
An image of a DNA sequencing spectrum with a radial blur filter applied.

A Comprehensive Guide to Next-Generation Sequencing

Integra Logo

Products

brandtech logo

BRANDTECH® Scientific Announces Strategic Partnership with Copia Scientific to Strengthen Sales and Service of the BRAND® Liquid Handling Station (LHS) 

Top Innovations 2026 Contest Image

Enter Our 2026 Top Innovations Contest

Biotium Logo

Biotium Expands Tyramide Signal Amplification Portfolio with Brighter and More Stable Dyes for Enhanced Spatial Imaging

Labvantage Logo

LabVantage Solutions Awarded $22.3 Million U.S Customs and Border Protection Contract to Deliver Next-Generation Forensic LIMS